Related Experiment Video
Updated: Jun 11, 2025

A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Treatments with versus without medication for children with behavioural difficulties in clinical practice: an
Caitlin K Kiernan1,2,3, Hermien H Dijk1,2,3, Barbara J van den Hoofdakker1,2,4
1Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Insights
This study found no significant cost-effectiveness differences between medication and non-medication treatments for children with behavioral issues like ADHD and ODD in real-world clinical practice. Further research is needed for definitive conclusions on treatment utility.
Area of Science:
- Pediatric mental healthcare
- Health economics
- Behavioral science
Background:
- Traditional economic evaluations for childhood behavioral disorders (ADHD/ODD) often use limited trial or model data.
- Real-world clinical practice data may offer more representative cost-effectiveness and cost-utility insights.
- This study addresses this gap by evaluating treatments using observational data.
Purpose of the Study:
- To conduct an economic evaluation of treatments for children experiencing hyperactivity, inattention, and behavioral difficulties.
- To compare the cost-effectiveness and cost-utility of medication versus non-medication treatments in a clinical setting.
- To utilize longitudinal observational data for a more practical assessment.
Main Methods:
- A longitudinal study of 209 children (aged 5-12) receiving youth mental healthcare.
- Comparison of treatment groups: with medication (n=108) and without medication (n=101).
- Propensity score matching ensured group comparability; outcomes included QALYs, symptom severity, and impairment; societal costs were assessed.
Main Results:
- No statistically significant differences in costs or effects were found between medication and non-medication treatment groups.
- Cost-effectiveness acceptability curves (CEACs) indicated a 55% probability of cost-effectiveness for medication at a €80,000 threshold.
- The probability of cost-effectiveness for medication decreased to 36% at a €20,000 threshold.
Conclusions:
- Observational data did not yield conclusive evidence on the cost-effectiveness or cost-utility of medication versus non-medication treatments in clinical practice.
- The findings highlight the complexity of economic evaluations in pediatric mental healthcare.
- Further investigation may be warranted to clarify the value of medication in treating childhood behavioral disorders.
Background:
Economic evaluations of treatments for children with behavioural difficulties (i.e., characteristics of attention-deficit/hyperactivity disorder (ADHD) and/or oppositional defiant disorder (ODD)) usually rely on data of randomised controlled trials or are model-based. Findings of such studies may not be representative of cost-effectiveness and cost-utility in clinical practice. The current longitudinal study aimed to perform an economic evaluation of treatments for children with hyperactivity, impulsive behaviours, inattention, and/or behavioural difficulties using observational data that were obtained in clinical practice.
Methods:
Parents of 209 children (aged 5-12) who were referred to 1 of 10 Dutch youth mental healthcare institutions and who received treatment with (n = 108) or without (n = 101) the use of medication, filled out questionnaires at three timepoints (baseline, and ~ 6 and ~12 months later). Propensity score matching was used to make both groups comparable. Outcomes included quality-adjusted life years (QALYs), ADHD and ODD symptom severity, and impairment. Costs were measured from a societal perspective. Incremental cost-effectiveness ratios (ICERs) were estimated, and cost-effectiveness acceptability curves (CEACs) were derived to show uncertainty around the ICER.
Results:
Results did not show statistically significant differences in costs and effects between children who were treated with medication (alone or in combination with non-medication treatment) and those who were treated without medication. CEAC suggested that medication treatment has a 55% probability of being cost-effective at the €80,000 threshold and 36% at the €20,000 threshold compared with treatment without medication.
Conclusions:
Using observational data, our study did not provide clear evidence of the cost-effectiveness and cost-utility of treatment with medication compared with treatment without medication in clinical practice.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Related Concept Videos
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Drug Therapy
Antianxiety Medications
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Behavior Modification
A real-world application of operant conditioning principles is applied...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...